The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization
Open accessAbstract
There is a continued desire in biomedical research to reduce the number and duration of design cycles required to optimize lead compounds into high-quality chemical probes or safe and efficacious drug candidates. The insightful application of impactful molecular design elements is one approach toward achieving this goal. The replacement of a CH group with a N atom in aromatic and heteroaromatic ring systems can have many important effects on molecular and physicochemical properties and intra- and intermolecular interactions that can translate to improved pharmacological profiles. In this Perspective, the "necessary nitrogen atom" is shown to be a versatile high-impact design element for multiparameter optimization, wherein ≥10-, 100-, or 1000-fold improvement in a variety of key pharmacological parameters can be realized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
van der Waals Volumes and Radii
Bondi, A. (1964) · The Journal of Physical Chemistry · doi:10.1021/j100785a001 · Cited by 19,350
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Vitaku, E., Smith, D. T., & Njardarson, J. T. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501100b · Cited by 6,418
How to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566
Ertl, P., Rohde, B., & Selzer, P. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000942e · Cited by 3,084
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Meanwell, N. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013693 · Cited by 2,854
Rings in Drugs: Miniperspective
Taylor, R. D., MacCoss, M., & Lawson, A. D. G. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4017625 · Cited by 2,543
A Medicinal Chemist’s Guide to Molecular Interactions
Bissantz, C., Kuhn, B., & Stahl, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100112j · Cited by 1,731
Profound Methyl Effects in Drug Discovery and a Call for New CH Methylation Reactions
Schönherr, H., & Cernak, T. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201303207 · Cited by 1,094
The promise and peril of chemical probes
Arrowsmith, C. H., Audia, J. E., Austin, C., Baell, J., Bennett, J., Blagg, J., Bountra, C., Brennan, P. E., Brown, P. J., Bunnage, M. E., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1867 · Cited by 839
A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design
Beno, B. R., Yeung, K.-S., Bartberger, M. D., Pennington, L. D., & Meanwell, N. A. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501853m · Cited by 772
Self-citationOPLS all-atom force field for carbohydrates
Damm, W., Frontera, A., Tirado‐Rives, J., & Jorgensen, W. L. (1997) · Journal of Computational Chemistry · doi:10.1002/(sici)1096-987x(199712)18:16<2060::aid-jcc10>3.0.co;2-s · Cited by 710
Meanwell, N. A. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200211v · Cited by 620
Mecozzi, S., West, A. P., & Dougherty, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10566 · Cited by 592
Intramolecular Hydrogen Bonding in Medicinal Chemistry
Kuhn, B., Mohr, P., & Stahl, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100087s · Cited by 571
CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure
Rankovic, Z. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501535r · Cited by 548
Cation−π Interactions in Simple Aromatics: Electrostatics Provide a Predictive Tool
Mecozzi, S., West, A. P., & Dougherty, D. A. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9539608 · Cited by 506
Lead‐Oriented Synthesis: A New Opportunity for Synthetic Chemistry
Nadin, A., Hattotuwagama, C., & Churcher, I. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201105840 · Cited by 390
X-ray structure of the mouse serotonin 5-HT3 receptor
Hassaine, G., Deluz, C., Grasso, L., Wyss, R., Tol, M. B., Hovius, R., Graff, A., Stahlberg, H., Tomizaki, T., Desmyter, A., et al. (2014) · Nature · doi:10.1038/nature13552 · Cited by 383
Effects of Heteroatoms on Aromatic π−π Interactions: Benzene−Pyridine and Pyridine Dimer
Hohenstein, E. G., & Sherrill, C. D. (2009) · The Journal of Physical Chemistry A · doi:10.1021/jp809062x · Cited by 373
The p KBHX Database: Toward a Better Understanding of Hydrogen-Bond Basicity for Medicinal Chemists
Laurence, C., Brameld, K. A., Graton, J., Le Questel, J.-Y., & Renault, E. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801331y · Cited by 346
Chemical predictive modelling to improve compound quality
Cumming, J. G., Davis, A. M., Muresan, S., Haeberlein, M., & Chen, H. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4128 · Cited by 311
Pierre, F., Chua, P. C., O’Brien, S. E., Siddiqui-Jain, A., Bourbon, P., Haddach, M., Michaux, J., Nagasawa, J., Schwaebe, M. K., Stefan, E., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101251q · Cited by 296
Mitigating Heterocycle Metabolism in Drug Discovery
Jean, D. J. S., & Fotsch, C. H. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300343m · Cited by 263
Michel, J., Tirado-Rives, J., & Jorgensen, W. L. (2009) · Journal of the American Chemical Society · doi:10.1021/ja906058w · Cited by 256
Thermodynamics of solute transfer from water to hexadecane
Abraham, M. H., Whiting, G. S., Fuchs, R., & Chambers, E. J. (1990) · Journal of the Chemical Society, Perkin Transactions 2 · doi:10.1039/p29900000291 · Cited by 218
Structural Modifications that Alter the P-Glycoprotein Efflux Properties of Compounds
Hitchcock, S. A. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201136z · Cited by 217
Acidic and Basic Drugs in Medicinal Chemistry: A Perspective
Charifson, P. S., & Walters, W. P. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501000a · Cited by 208
Heteroaromatic π-Stacking Energy Landscapes
Huber, R. G., Margreiter, M. A., Fuchs, J. E., von Grafenstein, S., Tautermann, C. S., Liedl, K. R., & Fox, T. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500183u · Cited by 205
Verhoest, P. R., Chapin, D. S., Corman, M., Fonseca, K., Harms, J. F., Hou, X., Marr, E. S., Menniti, F. S., Nelson, F., O’Connor, R., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900521k · Cited by 205
Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor
Johnson, D. S., Stiff, C., Lazerwith, S. E., Kesten, S. R., Fay, L. K., Morris, M., Beidler, D., Liimatta, M. B., Smith, S. E., Dudley, D. T., et al. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100190t · Cited by 199
Rational Use of Plasma Protein and Tissue Binding Data in Drug Design
Liu, X., Wright, M. R., & Hop, C. E. C. A. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5007935 · Cited by 190
Perola, E. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100118x · Cited by 188
Ritchie, T. J., Macdonald, S. J. F., Peace, S., Pickett, S. D., & Luscombe, C. N. (2012) · MedChemComm · doi:10.1039/c2md20111a · Cited by 183
Multi-Parameter Optimization: Identifying High Quality Compounds with a Balance of Properties
D. Segall, M. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799436430 · Cited by 172
Bioisosteres in Medicinal Chemistry
Brown, N. (2012) · Wiley eBooks · doi:10.1002/9783527654307 · Cited by 158
How hydrogen bonds impact P-glycoprotein transport and permeability
Desai, P. V., Raub, T. J., & Blanco, M.-J. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.08.059 · Cited by 141
A Real-World Perspective on Molecular Design
Kuhn, B., Guba, W., Hert, J., Banner, D. W., Bissantz, C., Ceccarelli, S., Haap, W. J., Körner, M., Kuglstatter, A., Lerner, C., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01875 · Cited by 120
D’Angelo, N. D., Kim, T., Andrews, K. L., Booker, S. K., Caenepeel, S. R., Chen, K., D’Amico, D. C., Freeman, D., Jiang, J. W., Liu, L., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1014605 · Cited by 119
Statistical Analysis of the Effects of Common Chemical Substituents on Ligand Potency
Hajduk, P. J., & Sauer, D. R. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm070838y · Cited by 107
Doherty, E. M., Fotsch, C. H., Bannon, A. W., Bo, Y. Y., Chen, N., Dominguez, C., Falsey, J. R., Gavva, N. R., Katon, J. G., Nixey, T. E., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070190p · Cited by 104
Dubost⧫, E., Dumas, N., Fossey, C., Magnelli, R., Butt‐Gueulle, S., Ballandonne, C., Caignard, D. H., Dulin, F., Santos, J. S. O., Millet, P., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300943r · Cited by 103
Meanwell, N. A. (2013) · Topics in medicinal chemistry · doi:10.1007/7355_2013_29 · Cited by 100
Strategies for a comprehensive understanding of metabolism by aldehyde oxidase
Hutzler, J. M., Obach, R. S., Dalvie, D., & Zientek, M. A. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.738668 · Cited by 99
Chuprina, A., Lukin, O. V., Demoiseaux, R., Buzko, A., & Shivanyuk, A. N. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci900464s · Cited by 98
Guo, L., Aschenbach, L. C., Chen, J., Cassidy, M. P., Stevens, D. L., Gabra, B. H., Selley, D. E., Dewey, W. L., Westkaemper, R. B., & Zhang, Y. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801272c · Cited by 94
Cid, J. M., Tresadern, G., Vega, J. A., de Lucas, A. I., Matesanz, E., Iturrino, L., Linares, M. L., Molina, A. G., Andrés, J. I., Macdonald, G. J., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3010724 · Cited by 93
Vanotti, E., Amici, R., Bargiotti, A., Berthelsen, J., Bosotti, R., Ciavolella, A., Cirla, A., Cristiani, C., D’Alessio, R., Forte, B., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm700956r · Cited by 93
Henry, J. R., Kaufman, M. D., Peng, S.-B., Ahn, Y. M., Caldwell, T. M., Vogeti, L., Telikepalli, H., Lu, W.-P., Hood, M. M., Rutkoski, T. J., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00067 · Cited by 89
Li, J. J., Nahra, J., Johnson, A. R., Bunker, A. M., O’Brien, P., Yue, W.-S., Ortwine, D. F., Man, C.-F., Baragi, V., Kilgore, K. S., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701274v · Cited by 88
Sanoh, S., Tayama, Y., Sugihara, K., Kitamura, S., & Ohta, S. (2014) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2014.10.009 · Cited by 84
Shamovsky, I. L., Ripa, L., Börjesson, L., Mee, C. D., Nordén, B., Hansen, P., Hasselgren, C., O'Donovan, M. R., & Sjö, P. (2011) · Journal of the American Chemical Society · doi:10.1021/ja206427u · Cited by 84
Zheng, X., Bauer, P., Baumeister, T., Buckmelter, A. J., Caligiuri, M., Clodfelter, K. H., Han, B., Ho, Y., Kley, N., Lin, J., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400186h · Cited by 81
Li, Z., Wang, X., Eksterowicz, J. E., Gribble, M., Alba, G., Ayres, M., Carlson, T. J., Chen, A., Chen, X., Cho, R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500118j · Cited by 81
The Impact of Chemical Probes in Drug Discovery: A Pharmaceutical Industry Perspective
Garbaccio, R. M., & Parmee, E. R. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2015.11.011 · Cited by 81
O’Donnell, C. J., Rogers, B. N., Bronk, B. S., Bryce, D. K., Coe, J. W., Cook, K. K., Duplantier, A. J., Evrard, E., Hajós, M., Hoffmann, W. E., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9015075 · Cited by 80
Matched Molecular Pair Analysis: Significance and the Impact of Experimental Uncertainty
Krämer, C., Fuchs, J. E., Whitebread, S., Gedeck, P., & Liedl, K. R. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500317a · Cited by 77
Solubility of Benzene in Water.
Arnold, D., Plank, C. J., Erickson, E. E., & Pike, F. P. (1958) · Industrial & Engineering Chemistry Chemical & Engineering Data Series · doi:10.1021/i460004a016 · Cited by 74
Lead Optimization of Spiropyrazolopyridones: A New and Potent Class of Dengue Virus Inhibitors
Zou, B., Chan, W. L., Ding, M., Leong, S. Y., Nilar, S., Seah, P. G., Liu, W., Karuna, R., Blasco, F., Yip, A., et al. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500521r · Cited by 74
N -naphthoyl-β-naltrexamine (NNTA), a highly selective and potent activator of μ/κ-opioid heteromers
Yekkirala, A. S., Lunzer, M. M., McCurdy, C. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016277108 · Cited by 68
Safina, B. S., Baker, S. J., Baumgardner, M., Blaney, P. M., Chan, B. K., Chen, Y., Cartwright, M. W., Castanedo, G. M., Chabot, C., Cheguillaume, A., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3003747 · Cited by 66
Fox, B. M., Beck, H. P., Roveto, P. M., Kayser, F., Cheng, Q., Dou, H., Williamson, T. L., Treanor, J. J. S., Liu, H., Jin, L., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00567 · Cited by 66
Wassermann, A. M., & Bajorath, J. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci1001845 · Cited by 64
Hydrogen Bond Basicity Prediction for Medicinal Chemistry Design
Kenny, P. W., Montanari, C. A., Prokopczyk, I. M., Ribeiro, J. F. R., & Sartori, G. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01946 · Cited by 64
Cioffi, C. L., Dobri, N., Freeman, E. E., Conlon, M. P., Chen, P., Stafford, D. G., Schwarz, D. M. C., Golden, K. C., Zhu, L., Kitchen, D. B., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5010013 · Cited by 63
7-Azaindenoisoquinolines as Topoisomerase I Inhibitors and Potential Anticancer Agents
Kiselev, E., DeGuire, S. M., Morrell, A. E., Agama, K., Dexheimer, T. S., Pommier, Y. G., & Cushman, M. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200719v · Cited by 61
Extraction of tacit knowledge from large ADME data sets via pairwise analysis
Keefer, C. E., Chang, G., & Kauffman, G. W. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.05.003 · Cited by 61
Morales, G. A., Garlich, J. R., Su, J., Peng, X., Newblom, J., Weber, K. T., & Durden, D. L. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301522m · Cited by 58
Sutherland, J. J., Raymond, J. W., Stevens, J. L., Baker, T. K., & Watson, D. E. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300684u · Cited by 58
Large-Scale Exploration of Bioisosteric Replacements on the Basis of Matched Molecular Pairs
Wassermann, A. M., & Bajorath, J. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.10.293 · Cited by 54
Matched molecular pairs derived by retrosynthetic fragmentation
de León, A. D. L. V., & Bajorath, J. (2013) · MedChemComm · doi:10.1039/c3md00259d · Cited by 53
Borrmann, T., Abdelrahman, A., Volpini, R., Lambertucci, C., Alksnis, E., Gorzalka, S., Knospe, M., Schiedel, A. C., Cristalli, G., & Müller, C. E. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9006356 · Cited by 51
Govek, S. P., Nagasawa, J. Y., Douglas, K. L., Lai, A. G., Kahraman, M., Bonnefous, C., Aparicio, A. M., Darimont, B. D., Grillot, K. L., Joseph, J. D., et al. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.09.074 · Cited by 50
Tactical Approaches to Interconverting GPCR Agonists and Antagonists
Dosa, P. I., & Amin, E. A. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00982 · Cited by 50
Synthesis, SAR, and Pharmacological Characterization of Brain Penetrant P2X7 Receptor Antagonists
Savall, B. M., Wu, D., Angelis, M. D., Carruthers, N. I., Ao, H., Wang, Q., Lord, B., Bhattacharya, A., & Letavic, M. A. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00089 · Cited by 50
Leach, A. G., & Kidley, N. J. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci2000506 · Cited by 49
Yokokawa, F., Wang, G., Chan, W. L., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400071a · Cited by 48
Lawhorn, B. G., Philp, J., Zhao, Y., Louer, C. T., Hammond, M., Cheung, M., Fries, H. E., Graves, A. P., Shewchuk, L. M., Wang, L., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00931 · Cited by 48
Yuan, Y., Zaidi, S. A., Elbegdorj, O., Aschenbach, L. C., Guo, L., Stevens, D. L., Scoggins, K. L., Dewey, W. L., Selley, D. E., & Zhang, Y. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4012214 · Cited by 47
Design, Synthesis, and Structure–Activity Relationships of Highly Potent 5-HT3Receptor Ligands
Verheij, M. H. P., Thompson, A. J., van Muijlwijk‐Koezen, J. E., Lummis, S. C. R., Leurs, R., & de Esch, I. J. P. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300801u · Cited by 41
Traquandi, G., Ciomei, M., Ballinari, D., Casale, E., Colombo, N., Croci, V., Fiorentini, F., Isacchi, A., Longo, A., Mercurio, C., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901710h · Cited by 41
Physical Properties in Drug Design
Young, R. J. (2014) · Topics in medicinal chemistry · doi:10.1007/7355_2013_35 · Cited by 40
Atropisomeric 4-Phenyl-4H-1,2,4-triazoles as Selective Glycine Transporter 1 Inhibitors
Sugane, T., Tobe, T., Hamaguchi, W., Shimada, I., Maeno, K., Miyata, J., Suzuki, T., Kimizuka, T., Sakamoto, S., & Tsukamoto, S. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400383w · Cited by 39
Shin, Y., Suchomel, J., Cardozo, M. G., Duquette, J., He, X., Henne, K. R., Hu, Y., Kelly, R. C., McCarter, J. D., McGee, L. R., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01651 · Cited by 35
Huang, H., Degnan, A. P., Balakrishnan, A., Easton, A. E., Gulianello, M., Huang, Y., Matchett, M., Mattson, G. K., Miller, R., Santone, K. S., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.07.065 · Cited by 30
Barsanti, P. A., Pan, Y., Lu, Y., Jain, R., Cox, M. O., Aversa, R. J., Dillon, M. P., Elling, R. A., Hu, C., Jin, X., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500352s · Cited by 29
Optimization of novel di-substituted cyclohexylbenzamide derivatives as potent 11β-HSD1 inhibitors
McMinn, D. L., Rew, Y., Sudom, A. M., Caille, S., DeGraffenreid, M. R., He, X., Hungate, R. W., Jiang, B., Jaén, J. C., Julian, L. D., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.026 · Cited by 28
Potent Heterocyclic Ligands for Human Complement C3a Receptor
Reid, R. C., Yau, M., Singh, R., Hamidon, J. K., Lim, J., Stoermer, M. J., & Fairlie, D. P. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500956p · Cited by 28
Ellis, J. M., Altman, M. D., Bass, A. S., Butcher, J. W., Byford, A. J., Donofrio, A. E., Galloway, S. M., Haidle, A. M., Jewell, J. P., Kelly, N., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm5018169 · Cited by 26
Fukaya, T., Ishiyama, T., Baba, S., & Masumoto, S. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401325r · Cited by 19
Pennington, L. D., Croghan, M. D., Sham, K. K. C., Pickrell, A. J., Harrington, P. E., Frohn, M. J., Lanman, B. A., Reed, A. B., Lee, M. R., Xu, H., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.10.085 · Cited by 18
Self-citationLingam, V. S. P. R., Dahale, D. H., Rathi, V. E., Shingote, Y. B., Thakur, R. R., Mindhe, A. S., Kummari, S., Khairatkar-Joshi, N., Bajpai, M., Shah, D., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01240 · Cited by 17
Substituted phenyl triazoles as selective inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1
Sun, W., Maletic, M. M., Mundt, S. S., Shah, K., Zokian, H. J., Lyons, K., Waddell, S. T., & Balkovec, J. M. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.125 · Cited by 14
Zanaletti, R., Bettinetti, L., Castaldo, C., Ceccarelli, I., Cocconcelli, G., Comery, T. A., Dunlop, J., Genesio, E., Ghiron, C., Haydar, S. N., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3013568 · Cited by 14
Leishman, D. J., & Ranković, Z. (2014) · Topics in medicinal chemistry · doi:10.1007/7355_2014_38 · Cited by 11
Avoiding PXR and CAR Activation and CYP3A4 Enzyme Induction
Sinz, M. (2013) · Topics in medicinal chemistry · doi:10.1007/7355_2013_24 · Cited by 8
Dimova, D., Stumpfe, D., & Bajorath, J. (2014) · MedChemComm · doi:10.1039/c4md00029c · Cited by 8
Matched molecular pair-based data sets for computer-aided medicinal chemistry
Hu, Y., de León, A. D. L. V., Zhang, B., & Bajorath, J. (2014) · F1000Research · doi:10.12688/f1000research.3-36.v1 · Cited by 8
Tactics to Avoid Inhibition of Cytochrome P450s
Leach, A. G. (2013) · Topics in medicinal chemistry · doi:10.1007/7355_2013_25 · Cited by 6
Optimizing Pharmacokinetic Properties and Attaining Candidate Selection
Ward, K. W. (2012) · Topics in medicinal chemistry · doi:10.1007/7355_2012_19 · Cited by 5
The Role of Biotransformation Studies in Reducing Drug Attrition
Spracklin, D. K., Kalgutkar, A. S. S., & Nedderman, A. N. R. (2013) · Topics in medicinal chemistry · doi:10.1007/7355_2012_18 · Cited by 2
Cited by
Bioisosteres of the Phenyl Ring: Recent Strategic Applications in Lead Optimization and Drug Design
Subbaiah, M. A. M., & Meanwell, N. A. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01215 · Cited by 710
Shultz, M. D. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00686 · Cited by 434
Pratley, C., Fenner, S., & Murphy, J. A. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00831 · Cited by 422
The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design
Ling, Y., Hao, Z.-Y., Liang, D., Zhang, C.-L., Liu, Y.-F., & Wang, Y. (2021) · Drug Design, Development and Therapy · doi:10.2147/dddt.s329547 · Cited by 414
Lipophilic Efficiency as an Important Metric in Drug Design
Johnson, T. W., Gallego, R. A., & Edwards, M. P. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00077 · Cited by 349
Metadata
- Authors
- Pennington, L. D., & Moustakas, D. T.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-02-08
- Volume
- 60
- Issue
- 9
- Pages
- 3552-3579
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2587696209
- Cited by
- 408
- References
- 101
- FWCI
- 16.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.